Physician profile
Jeffrey H Barton
NPI 1962450304
$747.61
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $66.83 · 2021: $21.11 · 2022: $125 · 2023: $288 · 2024: $22.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $310.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $150.68 | 2019-2023 | Liletta, Lo Loestrin Fe, Orilissa |
| Bayer Healthcare Pharmaceuticals INC. | $118.62 | 2019-2023 | |
| Exeltis, USA INC. | $94.76 | 2020-2023 | Slynd |
| Organon LLC | $92.43 | 2021-2023 | Nexplanon |
| Medtronic, INC. | $77.44 | 2022-2023 | Truclear |
| Roche Diagnostics Corporation | $75.52 | 2019 | |
| Hologic Sales and Service, LLC | $35.94 | 2019-2024 | Omni Hysteroscope |
| Allergan, INC. | $35.00 | 2019 | |
| Daiichi Sankyo INC. | $28.63 | 2022-2023 | Injectafer |
| Acessa Health INC. | $21.09 | 2019 | |
| Duchesnay USA Incorporated | $17.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Barton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.